Article info
Neurodegeneration
Original research
Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion
- Correspondence to Professor Markus Otto, Department of Neurology, Ulm University, Ulm, Baden-Württemberg, Germany; markus.otto{at}uk-halle.de
Citation
Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion
Publication history
- Received November 29, 2021
- Accepted February 15, 2022
- First published April 27, 2022.
Online issue publication
May 29, 2023
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.